AN ENTIRELY new class of anti-inflammatory medication developed in Australia is being prepared for regulatory approval, targeting the fundamental process of inflammation - see more HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jul 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
